121 related articles for article (PubMed ID: 6337030)
21. Effect of clonidine therapy on renal hemodynamics in renal transplant hypertension.
Green S; Zawada ET; Muakkassa W; Johnson M; Mackenzie T; McClanahan M; Graybill A; Goldman M
Arch Intern Med; 1984 Jun; 144(6):1205-8. PubMed ID: 6375612
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme inhibition in renal and hypertensive disorders.
Götz R; Heidbreder E; Heidland A
Clin Physiol Biochem; 1990; 8 Suppl 1():25-32. PubMed ID: 2257721
[TBL] [Abstract][Full Text] [Related]
23. The effect of nisoldipine on renal function in the long-term treatment of hypertension in patients with and without renal impairment.
Wilson J; Wahbha MM; Martin PG; Hainsworth R; Brownjohn AM; Turney JH; Davies JA; Prentice CR
Eur J Clin Pharmacol; 1989; 37(5):437-41. PubMed ID: 2689184
[TBL] [Abstract][Full Text] [Related]
24. [Effects of prolonged treatment with labetalol on renal function and on water and saline metabolism in essential and reno-parenchymal hypertension].
Valvo E; Tessitore N; Previato G; Lupo A; Lo Schiavo C; Tornieri G; Maschio G
Minerva Nefrol; 1979; 26(1):1-3. PubMed ID: 471316
[No Abstract] [Full Text] [Related]
25. Comparative effects of captopril and nifedipine on split renal function in renovascular hypertension.
Miyamori I; Yasuhara S; Matsubara T; Takasaki H; Takeda R
Am J Hypertens; 1988 Oct; 1(4 Pt 1):359-63. PubMed ID: 3063285
[TBL] [Abstract][Full Text] [Related]
26. Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation.
Navis GJ; de Zeeuw D; de Jong PE
J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S30-4. PubMed ID: 2422491
[TBL] [Abstract][Full Text] [Related]
27. Effect of indomethacin on renal function and plasma renin activity in dogs with chronic renovascular hypertension.
Yun J; Kelly G; Bartter FC
Nephron; 1979; 24(6):278-82. PubMed ID: 514427
[TBL] [Abstract][Full Text] [Related]
28. Changes in renal function induced by endralazine, a new antihypertensive drug.
Wegmüller E; Reubi FC
Eur J Clin Pharmacol; 1983; 24(3):307-14. PubMed ID: 6345175
[No Abstract] [Full Text] [Related]
29. Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.
Hollenberg NK; Swartz SL; Passan DR; Williams GH
N Engl J Med; 1979 Jul; 301(1):9-12. PubMed ID: 221809
[TBL] [Abstract][Full Text] [Related]
30. Alterations in renal hemodynamics during chronic and acute beta-blockade in humans.
Beaufils M
Am J Hypertens; 1989 Nov; 2(11 Pt 2):233S-236S. PubMed ID: 2573369
[TBL] [Abstract][Full Text] [Related]
31. Acute and chronic renal effects of guanfacine in essential and renal hypertension.
Roeckel A; Heidland A
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):141S-149S. PubMed ID: 6994769
[TBL] [Abstract][Full Text] [Related]
32. Hormonal and hemodynamic effects of short- and long-term clonidine therapy in patients with mild-to-moderate hypertension.
Golub MS; Thananopavarn C; Eggena P; Barrett JD; Sambhi MP
Chest; 1983 Feb; 83(2 Suppl):377-9. PubMed ID: 6822131
[TBL] [Abstract][Full Text] [Related]
33. Glomerular hyperfiltration in essential hypertension: hormonal aspects.
Regolisti G; Buzio C; Cavatorta A; De Martin L; Cavalli R; Perazzoli F; Coghi P; Cabassi A; Pucci F; Borghetti A
Acta Biomed Ateneo Parmense; 1992; 63(1-2):163-73. PubMed ID: 1340661
[TBL] [Abstract][Full Text] [Related]
34. Reduced renovascular resistance by clonidine.
Cohen IM; O'Connor DT; Preston RA; Stone RA
Clin Pharmacol Ther; 1979 Nov; 26(5):572-7. PubMed ID: 498699
[TBL] [Abstract][Full Text] [Related]
35. [The possibility of predicting the hypotensive effect of the surgical treatment of nephrogenic hypertension].
Dzhavad-Zade MD; Figarov IG; Dzemilev IA; Samedov RN
Vestn Khir Im I I Grek; 1992; 149(7-8):39-44. PubMed ID: 1341358
[TBL] [Abstract][Full Text] [Related]
36. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
[TBL] [Abstract][Full Text] [Related]
37. Influence of antihypertensive therapy on renal function.
Frei U; Schindler R; Koch KM
Clin Investig; 1992; 70 Suppl 1():S120-6. PubMed ID: 1591504
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
Anderson S; Rennke HG; Brenner BM
J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863
[TBL] [Abstract][Full Text] [Related]
39. ACE inhibitors in renal disease.
Bauer JH; Reams GP
Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV38-43; discussion IV51-5. PubMed ID: 1893641
[TBL] [Abstract][Full Text] [Related]
40. Renal effects of nitrendipine monotherapy in essential hypertension.
Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
